Gene expression and methylation status of 14-3-3σ in human renal carcinoma tissues

IUBMB Life

Volumn 60, Issue 8, 2008, Pages 534-540

  Liang, Shufang ^a   Xu, Yuhuan ^a   Shen, Guobo ^a   Zhao, Xinyu ^a   Zhou, Jin ^a   Li, Xingbin ^a   Gong, Fengming ^a   Ling, Bo ^b   Fang, Li ^c   Huang, Canhua ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c FIRST AFFILIATED HOSPITAL   (China)

Author keywords

14 3 3 ; DNA methylation; Renal cell carcinoma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; MESSENGER RNA; STRATIFIN; PRIMER DNA; PROTEIN 14 3 3;

ARTICLE; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; DEMETHYLATION; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; METHYLATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CARCINOMA; COMPARATIVE STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

14-3-3 PROTEINS; CARCINOMA; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 52049093688     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.75     Document Type: Article

References (37)

1. James, G., Herman M. D., Stephen, B., and Baylin, M. D. (2003) Gene silencing in cancer is association with promoter hypermethylation. N. Engl. J. Med. 349, 2042-2054.
2. Kass, S.U., Pruss, D., and Wolffe, A. P. (1997) How does DNA methylation repress transcription? Trends Genet. 13, 444-449.
3. Lodygin, D. and Hermeking, H. (2005) The role of epigenetic inactivation of 14-3-3σ in human cancer. Cell Res. 15, 237-246. (Pubitemid 41642879)
4. Takai, D., and Jones, P. A. (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. USA 99, 3740-3745.
5. Kang, G. H., Lee, S., Cho, N. Y., Gandamihardja, T., Long, T. I., Weisenberger, D. J., Campan, M., and Laird, P. W. (2008) DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis. Lab. Invest. 88, 161-170.
6. Hermeking, H. (2003) The14-3-3 cancer connection. Nat. Rev. Cancer 3, 931-943.
7. Hermeking, H., Lengauer, C., Polyak, K., He, T. C., Zhang, L., Thiagalingam, S., Kinzler, K. W., and Vogelstein, B. (1997) 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1, 3-11. (Pubitemid 127376388)
8. Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A., Hermeking, H., Marks, J. R., Lambers, A. R., Futreal, P. A., Stampfer, M. R., and Sukumar, S. (2000) High frequency of hypermethylation at the 14-3-3σ locus leads to gene silencing in breast cancer. PNAS. 97, 6049-6054. (Pubitemid 30367521)
9. Iwata, N., Yamamoto, H., Sasaki, S., Itoh, F., Suzuki, H., Kikuchi, T., Kaneto, H., Iku, S., Ozeki, I., Karino, Y., Satoh, T., Toyota, J., Satoh, M., Endo, T., and Imai, K. (2000) Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3σ gene in human hepatocellular carcinoma. Oncogene 19, 5298-5302.
10. Lee, S., Kim, W. H., Jung, H. Y., Yang, M. H., and Kang, G. H. (2002) Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma. Am. J. Pathol. 161, 1015-1022.
11. Osada, H., Tatematsu, Y., Yatabe, Y., Nakagawa, T., Konishi, H., Harano, T., Tezel, E., Takada, M., and Takahashi, T. (2002) Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers. Oncogene 21, 2418-2424. (Pubitemid 34407301)
12. Gasco, M., Sullivan, A., Repellin, C., Brooks, L., Farrell, P. J., Tidy, J.A., Dunne, B., Gusterson, B., Evans, D., and Crook, T. (2002) Coincident inactivation of 14-3-3σ and p16INK4a is an early event in vulval squamous neoplasia. Oncogene 21, 1876-1881. (Pubitemid 34259190)
13. Gasco, M., Bell, A. K., Heath, V., Sullivan, A., Smith, P., Hiller, L., Yulug, I., Numico, G., Merlano, M., Farrell, P. J., Tavassoli, M., Gusterson, B., and Crook, T. (2002) Epigenetic inactivation of 14-3-3σ in oral carcinoma: association with p16INK4a silencing and human papillomavirus negativity. Cancer Res. 62, 2072-2076. (Pubitemid 34408454)
14. Lodygin, D., Yazdi, A. S., Sander, C. A., Herzinger, T., and Hermeking, H. (2003) Analysis of 14-3-3σ expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma. Oncogene 22, 5519-5524. (Pubitemid 37072207)
15. Kaneuchi, M., Sasaki, M., and Tanaka, Y. (2004) Expression and methylation status of 14-3-3σ gene can characterize the different histological features of ovarian cancer. Biochem. Biophys. Res. Commun. 316, 1156-1162.
16. Akahira, J., Sugihashi, Y., Suzuki, T., Ito, K., Niikura, H., Moriya, T., Nitta, M., Okamura, H., Inoue, S., Sasano, H., Okamura, K., and Yaegashi, N. (2004) Decreased expression of 14-3-3σ is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation. Clin. Cancer. Res. 10, 2687-2693.
17. Mhawech, P., Benz, A., Cerato, C., Greloz, V., Assaly, M., Desmond, J. C., Koeffler, H. P., Lodygin, D., Hermeking, H., Herrmann, F., and Schwaller, J. (2005) Downregulation of 14-3-3σ in ovary, prostate and endometrial carcinomas is associated with CpG island methylation. Mod. Pathol. 18, 340-348.
18. Lodygin, D., Dichoid, J., and Hermeking, H. (2004) Prostate cancer is characterized by epigenetic silencing of 14-3-3σ expression. Oncogene 23, 9034-9041. (Pubitemid 40013070)
19. Mhawect, P. (2005) 14-3-3 proteins-an update. Cell Res. 15, 228-236.
20. Mostfi, F. K., and Davis, C. J. (1998) WHO International Histological Classification of Tumours. Springer, Berlin.
21. Takahashi, M., the, B.T., and Kanayama, H. (2006) Elucidation of the molecular signatures of renal cell carcinoma by gene expression profiling. Int. J. Med. 53, 9-19.
22. Morris, M. R., Gentle, D., Abdulrahman, M., Clarke, N., Brown, M., Kishida, T., Yao, M., the, B. T., Latif, F., and Maher, E. R. (2008) Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma. British J. Cancer 98, 496-501.
23. Motzer, R. J., Mazumdar, M., Bacik, J., Russo, P., Berg, W. J., and Metz, E. M. (2000) Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma. J. Clin. Oncol. 18, 1928-1935.
24. Motzer, R. J., and Russo, P. (2000) Systemic therapy for renal cell carcinoma. J. Urol. 163, 408-417. (Pubitemid 30060482)
25. Qi, W. Q., Liu, X. B., Qiao, D. H., and Martinez, J. D. (2005) Isoform-specific expression of 14-3-3σ proteins in human lung cancer tissues. Int. J. Cancer 113, 359-363. (Pubitemid 40038701)
26. Sambrook, J., Fritsh, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
27. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821-9826.
28. Umbricht, C. B., Evron, E., Gabrielson, E., Ferguson, A., Marks, J., and Sukumar, S. (2001) Hypermethylation of 14-3-3σ (stratifin) is an early event in breast cancer. Oncogene 20, 3348-3353.
29. Bhatia, K., Siraj, A. K., Hussain, A., Bu, R., and Gutiérrez, M. I. (2003) The tumor suppressor gene 14-3-3sigma is commonly methylated in normal and malignant lymphoid cells. Cancer Epidemio. Biomakers Prev. 12, 165-169.
30. Henrique, R., Jeronimo, C., Hoque, M. O., Carvalho, A. L., Oliveira, J., Teixeira, M. R., Lopes, C., and Sidransky, D. (2005) Frequent 14-3-3σ promoter methylation in benign and malignant prostate lesions. DNA Cell Biol. 24, 264-269. (Pubitemid 40490265)
31. Hsieh, C. L. (1994) Dependence of transcriptional repression on CpG methylation density. Mol. Cell. Biol. 14, 5487-5494.
32. Kass, S. U., Goddard, J. P., and Adams, R. L. (1993) Inactive chromatin spreads from a focus of methylation. Mol. Cell. Biol. 13, 7372-7379.
33. Rideout, W. M., Versole-Cire, P. E., Spruck, C. H., Hustad, C. M., Coetzee, G. A., Gonzales, F. A., and Jones, P. A. (1994) Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation. Mol. Cell. Biol. 14, 6143-6152.
34. Cameron, E. E., Baylin, S. B., and Herman, J. G. (1999) p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood 94, 2445-2451.
35. Iacobuzio-Donahue, C. A., Maitra, A., Olsen, M., Lowe, A. W., Van Heek, N. T., Rosty, C., Walter, K., Sato, N., Parker, A., Ashfaq, R., Jaffee, E., Ryu, B., Jone, J., Eshleman, J. R., Yeo, C. J., Cameron, J. L., Kern, S. E., Hruban, R. H., Brown, P. O., and Goggins, M. (2003) Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol. 162, 1151-1162.
36. Singal, R. and Ginder, D. G. (1999) DNA methylation. Blood 93, 4059-4070.
37. Futscher, B. W., Oshiro, M. M., Wozniak, R. J., Holtan, N., Hanigan, C.L., Duan, H., and Domann, F. E. (2002) Role for DNA methylation in the control of cell type-specific maspin expression. Nat. Genet. 31, 175-179.